Status:

COMPLETED

Genetics of Beta Cell Failure in Mexican Americans

Lead Sponsor:

University of Southern California

Collaborating Sponsors:

Kaiser Permanente

Conditions:

Gestational Diabetes

Diabetes Type 2

Eligibility:

All Genders

8+ years

Brief Summary

This is a family based genotype-phenotype study designed to assess genetic and environmental influences on obesity, insulin resistance and beta cell function in the context of gestational diabetes.

Detailed Description

Mexican American women with prior gestational diabetes and their first degree relatives and Mexican American women with prior normal glucose tolerance in pregnancy are studied with detailed phenotypin...

Eligibility Criteria

Inclusion

  • INCLUSION CRITERIA
  • Probands with Prior Gestational Diabetes Mellitus ("GDM PROBANDS")
  • Mexican American (parents and at least 3/4 four grandparents
  • age \>18 years
  • GDM in singleton pregnancy in prior 5 years
  • impaired glucose levels or sum of five OGTT glucose values \>625 mg/dl on 75 gram oral glucose tolerance test
  • Fasting plasma glucose \<126 mg/dl
  • At least two adult siblings of cousin not known to have diabetes and available for phenotyping; .
  • Siblings and Cousins of GDM Probands
  • Full sibling or first cousin of GDM proband
  • Age \>18 yrs
  • Fasting plasma glucose \<126 mg/dl.
  • Parents, Uncles and Aunts of GDM Probands
  • Full blooded parent, uncle or aunt of GDM proband
  • Control Proband
  • Mexican American as defined for GDM probands
  • One glucose challenge test result \<120 mg/dl at \>24 weeks gestation
  • No diabetes in first degree relative
  • Frequency matched to GDM probands by distributions of age, BMI and parity.
  • Spouse of GDM or Control Proband
  • Spouse of GDM proband
  • Age \>18
  • At least one child with proband able to provide DNA
  • Child of Proband
  • Child of GDM or control proband and spouse who provided DNA
  • EXCLUSION CRITERIA
  • PROBANDS (GDM OR CONTROL):
  • Chronic medical illness or medication known to alter glucose/insulin metabolism
  • Current pregnancy or breastfeeding
  • Ilicit drug or alcohol abuse,
  • Inability or unwillingness to give informed consent.
  • SIBLINGS AND COUSINS OF PROBANDS:
  • Chronic medical illness or medication known to affect glucose/insulin metabolism
  • Current pregnancy or breastfeeding,
  • Ilicit drug or alcohol abuse
  • Inability or unwillingness to give informed consent.
  • PARENTS OF PROBANDS
  • Inability or unwillingness to give informed consent.
  • SPOUSE OF GDM or CONTROL PROBAND
  • Inability or unwillingness to give informed consent.
  • CHILD OF GDM or CONTROL PROBAND
  • Lack of parent consent or child assent.

Exclusion

    Key Trial Info

    Start Date :

    July 1 2001

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    May 31 2013

    Estimated Enrollment :

    1250 Patients enrolled

    Trial Details

    Trial ID

    NCT03301519

    Start Date

    July 1 2001

    End Date

    May 31 2013

    Last Update

    November 18 2023

    Active Locations (0)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 0 (0 locations)

    No Results Found

    We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.